thirteen patients with prl-secreting tumours ( pst ) , 10 acromegalics ( a ) and 8 patients with hypothalamic lesions ( hl ) , as assessed on clinical , radiological and surgical grounds , underwent on separate occasions acute testing with the opioid peptide fk 33-824 ( 0.5 mg iv ) , the indirect dopamine ( da ) agonist nomifensine ( nom , 200 mg po ) , the da receptor antagonist domperidone ( dom , 10 mg iv ) , trh ( 200 microgram iv ) and insulin ( itt , 0.10-0.15 iu/kg iv ) .
C0033371
prl
C1327616
secreting